Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Star Imaging And Path LabBOM:544482 -2.22%21 PS Ratio is 1.62 as of Aug. 09, 2026, which is 8% below its 10-year median of 1.77. GuruFocus rates BOM:544482 with a GF Score™ of 21/100. Among 200 Medical Diagnostics & Research companies, Star Imaging And Path Lab ranks better than 69.5% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Star Imaging And Path Lab's share price is ₹82.21.
Star Imaging And Path Lab's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹50.86. Hence, Star Imaging And Path Lab's PS Ratio for today is 1.62.
The historical rank and industry rank for Star Imaging And Path Lab's PS Ratio or its related term are showing as below:
BOM:544482'
s PS Ratio Range Over the Past 10 Years
Min: 1.03 Med: 1.77 Max: 3
Current: 1.62
During the past 5 years, Star Imaging And Path Lab's highest PS Ratio was 3.00. The lowest was 1.03. And the median was 1.77.
BOM:544482's PS Ratio is ranked better than 69.5% of 200
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.79
vs BOM:544482: 1.62
During the past 5 years, Star Imaging And Path Lab's highest 3-Year average Revenue per Share Growth Rate was 14.60% per year. The lowest was 6.50% per year. And the median was 10.55% per year.
Star Imaging And Path Lab (BOM:544482) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Star Imaging And Path Lab PS Ratio Related Terms
Star Imaging And Path Lab PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Star Imaging And Path Lab's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Star Imaging And Path Lab PS Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Star Imaging And Path Lab's PS Ratio distribution charts can be found below:
* The bar in red indicates where Star Imaging And Path Lab's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Star Imaging And Path Lab's Share Price of today is ₹82.21.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Star Imaging And Path Lab's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹50.86.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Star Imaging And Path Lab (BOM:544482) has a PS Ratio of 1.62 as of Aug. 09, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Star Imaging And Path Lab and its competitors. This is near median its historical median of 1.77. Over the past decade, Star Imaging And Path Lab's PS Ratio has ranged from 1.03 to 3.00. According to the industry distribution chart, Star Imaging And Path Lab ranks #61 out of 200 companies in the Medical Diagnostics & Research industry, placing it in the top 30.5%.
Is Star Imaging And Path Lab's PS Ratio too high?
Star Imaging And Path Lab's current PS Ratio of 1.62 is near median its 10-year median of 1.77. Over the past 10 years, this metric has ranged from a low of 1.03 to a high of 3.00. The Medical Diagnostics & Research industry median PS Ratio is 2.79. Star Imaging And Path Lab's value of 1.62 is 41.9% below this industry median. Based on the distribution chart, Star Imaging And Path Lab ranks #61 out of 200 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Star Imaging And Path Lab has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Star Imaging And Path Lab's PS Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Star Imaging And Path Lab ranks #61 out of 200 companies for PS Ratio. This puts Star Imaging And Path Lab in the upper half of its industry. The industry median PS Ratio is 2.79. Star Imaging And Path Lab's value of 1.62 is 41.9% below this benchmark. Historically, Star Imaging And Path Lab's own PS Ratio has ranged from 1.03 to 3.00 over the past decade. While the company's 10-year median is 1.77 vs. the industry median of 2.79, Star Imaging And Path Lab has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Diagnostics & Research company?
The median PS Ratio among Medical Diagnostics & Research companies is 2.79, based on 200 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Star Imaging And Path Lab's current PS Ratio of 1.62 is 41.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Star Imaging And Path Lab and its competitors. For the Medical Diagnostics & Research industry, the median PS Ratio is 2.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Star Imaging And Path Lab's current PS Ratio is 1.62, which is near median its own 10-year median of 1.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Star Imaging And Path Lab stock overvalued right now?
Star Imaging And Path Lab (BOM:544482) has a current PS Ratio of 1.62. The current PS Ratio is 1.62, which is near median its 10-year median of 1.77 and 41.9% below the Medical Diagnostics & Research industry median of 2.79. Star Imaging And Path Lab's overall GF Score™ is 21/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Star Imaging And Path Lab (BOM:544482), the current PS Ratio is 1.62 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Star Imaging And Path Lab Ltd operates a diagnostic testing network, NABL accredited, delivering pathology, radiology, Cardiology, and Neurology services in Delhi and Uttar Pradesh. It offers a comprehensive range of diagnostic imaging services and clinical laboratory tests, including both routine and specialized studies and profiles. These services are essential for the prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. The company's diagnostic imaging and radiology services encompass X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, ultrasounds, bone mineral densitometry, and mammography.
21GF Score
Get the complete analysis for BOM:544482
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544482 has been successfully added to your 
